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Abstract—Previous studies have suggested that some graph
properties of protein interaction networks might be related with
gene morbidity. In particular, it has been suggested that when
a polymorphism affects a gene, it is more likely to produce a
disease if the node degree in the interaction network is higher
than for other genes. However, these results do not take into
account the possible bias introduced by the variance in the
amount of information available for different genes. This work
models the relationship between the morbidity associated with
a gene and the degrees of the nodes in the protein interaction
network controlling the amount of information available in the
literature. A set of 7461 genes and 3665 disease identifiers
reported in the Online Mendelian Inheritance in Man (OMIM)
was mined jointly with 9630 nodes and 38756 interactions of the
Human Proteome Resource Database (HPRD). The information
available from a gene was measured through PubMed mining.
Results suggest that the correlation between the degree of a
node in the protein interaction network and its morbidity is
largely contributed by the information available from the gene.
Even though the results suggest a positive correlation between
the degree of a node and its morbidity while controlling the
information factor, we believe this correlation has to be taken
with caution for it can be affected by other factors not taken
into account in this study.
I. INTRODUCTION
High throughput protein interaction identification meth-
ods, like yeast two-hybrid [1], high-throughput mass-
spectrometry protein complex identification (HMS-PCI) [2],
tandem affinity purification (TAP) [3], correlated mRNA ex-
pression and others, have allowed in recent years the building
of large protein-protein interaction (PPI) networks, of a rela-
tively high reliability. Although graphs have some limitations
when modeling PPI networks, they have been widely used
to model these interaction networks [4], [5]. In addition,
graph theory has been applied to study PPI networks helping
to unveil some of their characteristic network properties.
Particularly, a great effort has been directed towards the
discovery of relationships between graph properties of PPI
networks and the morbidity of genes.
One of the most studied graph properties of PPI networks
is the node degree. The degree of a node in a graph is
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the number of adjacent nodes. In a PPI context, the degree
of a protein is the number of other proteins with which
it interacts. Some authors have suggested that morbidity is
related to node degree in interaction graphs [6], [7]. The idea
behind this statement is that mutations in highly connected
nodes could cause a major disruption of the network. Jeong et
al. stated that PPI networks, like other real-world networks,
have a scale-free topology, with few high-degree nodes
and many low-degree nodes, with the degree distribution
following a power law [8]. This kind of networks are known
to increase the robustness of the network to random errors.
However, these networks are vulnerable to errors in hub
nodes (nodes of high degree). Other studies have suggested
that the degree of nodes in PPI networks could be associated
with the lethality of genes, with lethal gene mutations having
higher degrees that non-lethal genes mutations in their graph
representation [6]. Furthermore, it has been suggested that
lethal genes could correspond to high-degree nodes that also
disconnect the PPI network upon removal [7]. These results
support the idea of morbidity of genes being a consequence
of their central role in the proteomic network, independently
of their biological function.
On the other hand, genes of known morbidity, along with
their neighborhood, tend to be more thoroughly studied, in
order to find additional modulating or cross-effect genes.
This could cause a bias in the amount of PPI informa-
tion available for genes, with morbid genes having more
interactions reported than non-morbid genes, just because
of the attention that the scientific community has payed to
them. This could contribute in a causal effect between gene
morbidity and node degree, and not the other way.
This work intends to further explore the relationship
between gene morbidity and node degree, taking into account
the number of publications for the different genes. In order
to properly study this relationship, variance of node degrees
should be explained by controlling the variance correspond-
ing to the information that has been published about the
genes they represent.
In this contribution, this is approached through a linear
model that relates gene morbidity and node degree, detaching
the variance caused by the varying amount of information.
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This amount of information is defined as the number of
publications for each gene.
II. MATERIALS AND METHODS
The Online Mendelian Inheritance in Man (OMIM)
database was used to obtain an estimation of the morbidity of
a gene [9]. OMIM’s data maps every reported human disease
to the set of gene symbols that have been discovered to cause
or modulate the anomaly. The morbid map used in this work
was retrieved from OMIM in Feb-05 2010. This data maps
7461 different genes to 3665 OMIM identifiers.
The Human Proteome Resource Database (HPRD) was
used to obtain protein interaction information [10]. This data
was retrieved from the HPRD website, version of Jul-06
2009, and transformed into an undirected graph of 9630
nodes and 38756 interactions.
A set of software tools were written to automatically
query PubMed web service in order to obtain an estimation
of the amount of information avaialable for a given gene.
This amount of information was estimated as the number
of different publication identifiers obtained when querying
single genes.
Of the 9630 nodes of the HPRD graph, 9374 could be
mapped to a gene symbol. For each mapped symbol the
following three measures were calculated: the node degree
in the protein interaction graph, the number of OMIM
identifiers (morbidity) and the number of PubMed identifiers
associated (amount of information). In order to study the
relationship between morbidity and degree, two samples
were compared. The case sample consisted of the degrees
of the 1873 genes that had at least one OMIM identifier
associated (morbid). The control sample consisted of the
degrees of equally sized randomly generated samples of non-
morbid genes. The difference between the two populations
was measured through a Mann-Whitney test, the null hypoth-
esis being that the degrees of the two samples were equally
distributed [11].
To further study the influence on the morbidity of a
gene, the average degree and amount of information were
calculated for each morbidity value. Then a linear model
was built in order to quantify this influence. The morbidity
was used as response variable, while amount of information
and degree were used as explicative variables. This model is
described by the following equation:
M = α1I¯M + α2D¯M + β (1)
where M are the different values of morbidity, I¯M is the
average number of publications for each value of M and
D¯M is the average degree for each value of M .
All the mining and computing steps were performed using
the R statistical programming language [12].
III. RESULTS
The results show statistically significant differences be-
tween degrees of morbid genes and degrees of non-morbid
genes (see Fig. 1), with a maximum p-value of 6.72e− 10.
This low value indicates that the null hypothesis does not
hold, and therefore the degrees of morbid genes are higher
than the degrees of non-morbid genes. This suggests that
the more interactions a gene has the more likely it is to be
related with diseases, which is coherent with previous results
[6]. Even though this result seems intuitive, the effect of
the varying amount of information available on the different
genes is not negligible.
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Fig. 1: Node degree distribution of genes in OMIM (con-
tinuous line) and genes not in OMIM (dashed line). The
differences where found to be statistically significant, with a
maximum p-value of 6.72e−10.
Genes were grouped according to the number of diseases
they are related with. Fig. 2a shows the distribution of the
node degrees with respect to the gene morbidity. Despite a
low correlation value of 0.20, a positive correlation seems
evident. However, this correlation could be affected by the
fact that genes related to diseases tend to be more studied.
Fig. 2b shows the distribution of the number of publications
for the genes with respect to their morbidity. A very strong
positive correlation seems obvious in this case too. In fact,
the correlation value 0.26 is higher than the correlation with
the degree.
In order to assess the effect of the variance in the amount
of information available for different genes, we normalized
the degree of the nodes, dividing it by the amount of
publications in which they appear:
Dn(g) =
D(g)
I(g)
(2)
where D(g) is the degree of gene g and I(g) is the amount
of information (number of publications) available for gene
g. Fig. 2c shows that when the number of interactions is
normalized in such a way the positive correlation with the
number of diseases is not as evident and the correlation value
drops to −0.12.
The results for the model built for Equation 1 are shown in
Tables I and II. The normally-distributed residuals (p-value
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(a) Average degree of nodes as a function of the
number of diseases related to them.
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(b) Average number of publications (in logarith-
mic scale) of nodes as a function of the diseases
related to them.
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(c) Degree of nodes, divided by their number of
publications, as a function of the diseases they
have been related to.
Fig. 2: Correlation with gene morbidity.
TABLE I: Residuals of the linear model
Min 1Q Median 3Q Max
−2.25 −1.43 −0.03 1.43 2.58
The residues appear to be normally distributed, with a p-value of 0.81 in a
two-sided Kolmogorov-Smirnov test.
of 0.81) indicate that the linear model is applicable to the
data. The low p-value of the model (1.41e−3) also suggests
that the model fits well the data. Fig. 3 shows some quality
measures that strengthen the confidence in the results of the
linear model. Fig. 3a shows that the standardized residuals fit
the theoretical quantiles relatively well. In addition, Fig. 3b
shows that all data points have a low Cook distance, meaning
that none of them is causing an important bias in the slope
of the regression line [13].
The statistical significance is one order of magnitude
higher for the number of publications than for the degree
of genes. This suggests that the effect produced by the
variance in the amount of information available for the genes
is more significant than the effect produced by the variance
in the degrees of the genes. Interestingly, the p-value for the
degree is yet significant. This means that when the variance
in the amount of information is controlled there is still a
considerable effect explained in the response variable. In
addition, the coefficient calculated for the degree variable is
an order of magnitude higher, meaning that given the same
amount of information on two genes, the number of diseases
they are related with grows at a relative high rate with their
degree.
IV. DISCUSSION
Our results show that when the number of publications
is not taken into account, there seems to exist a clear
relationship between node degree and gene morbidity. How-
ever, when the number of publications is in the model, this
relationship is not as evident.
TABLE II: Coefficients of the linear model
Estimate Std. Error t value Pr(> |t|)
β −1.75 1.48 −1.18 2.70e−1
α1 3.73e
−3
9.60e−4 3.89 3.67e−3
α2 8.29e
−2
3.41e−2 2.43 3.77e−2
Both the average degree and the average number of publications per disease are
statistically significant. However the number of publications has a significance an
order of magnitude higher than the degree. The linear regression has a p-value of
1.41e
−3.
There might be an inherent bias in PPI data due to
the variance in the amount of information available for
different genes. Genes related to diseases appear more in the
literature, since they are more interesting to clinical science.
In addition, their interacting partners are more thoroughly
discovered, since they are the most evident targets for
searching disease modulators or new candidate genes. Even
though the results suggest a positive correlation between the
degree of a node and its morbidity we believe this correlation
has to be taken with caution for it can be affected by other
factors not taken into account in this study.
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